Close

Analyst Round-Up InterMune (ITMN): 6 Downgrades Following FDA's Request for More Trials May 5, 2010 02:44PM
Notable Analyst Rating Changes 05/05: S, CAb, ERTS, AMMD Upgraded; ITMN, MRK, NWSA, MYGN Downgraded May 5, 2010 10:36AM
Intermune (ITMN) option prices expensive into FDA for request for additional data May 5, 2010 08:37AM
Canaccord Adams Downgraded InterMune (ITMN) to Hold, $10 Tgt May 5, 2010 08:37AM
Analysts Giddy About InterMune (ITMN) On Expected Pirfenidone Approval Mar 10, 2010 03:18PM


Mar 10, 2010 11:46AM Canaccord Adams Reiterates a 'Buy' on InterMune (ITMN); FDA Approval, Focus Shifts to Market Opportunity
Mar 10, 2010 10:45AM Notable Analyst Rating Changes 03/10: ITMN, RDN, EIX, IFSIA Upgraded; FACT, VALE, PSS, NLY, AVAV Downgraded
Mar 10, 2010 10:02AM Canaccord Adams Lifts Price Target On Intermune (ITMN) to 'Street High' $66/Share
Jan 21, 2010 07:24AM InterMune (ITMN) Prices 7M Common Offering at $14.10/Share